| Guidelines for the use of flow cytometry and cell sorting in immunological studies A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ... European journal of immunology 49 (10), 1457-1973, 2019 | 1914 | 2019 |
| Severe COVID-19 is marked by a dysregulated myeloid cell compartment J Schulte-Schrepping, N Reusch, D Paclik, K Baßler, S Schlickeiser, ... Cell 182 (6), 1419-1440. e23, 2020 | 1367 | 2020 |
| Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model K Ruscher, D Freyer, M Karsch, N Isaev, D Megow, B Sawitzki, J Priller, ... Journal of Neuroscience 22 (23), 10291-10301, 2002 | 661 | 2002 |
| Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans P Sagoo, E Perucha, B Sawitzki, S Tomiuk, DA Stephens, P Miqueu, ... The Journal of clinical investigation 120 (6), 1848-1861, 2010 | 599 | 2010 |
| SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis D Wendisch, O Dietrich, T Mari, S von Stillfried, IL Ibarra, M Mittermaier, ... Cell 184 (26), 6243-6261. e27, 2021 | 384 | 2021 |
| Expression of p16INK4a and other cell cycle regulator and senescence associated genes in aging human kidney A Melk, BMW Schmidt, O Takeuchi, B Sawitzki, DC Rayner, PF Halloran Kidney international 65 (2), 510-520, 2004 | 376 | 2004 |
| IFN-γ production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo B Sawitzki, CI Kingsley, V Oliveira, M Karim, M Herber, KJ Wood The Journal of experimental medicine 201 (12), 1925-1935, 2005 | 370 | 2005 |
| Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus C von Spee-Mayer, E Siegert, D Abdirama, A Rose, A Klaus, T Alexander, ... Annals of the rheumatic diseases 75 (7), 1407-1415, 2016 | 360 | 2016 |
| Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials B Sawitzki, PN Harden, P Reinke, A Moreau, JA Hutchinson, DS Game, ... The Lancet 395 (10237), 1627-1639, 2020 | 356 | 2020 |
| Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19 JP Bernardes, N Mishra, F Tran, T Bahmer, L Best, JI Blase, D Bordoni, ... Immunity 53 (6), 1296-1314. e9, 2020 | 333 | 2020 |
| Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children J Loske, J Röhmel, S Lukassen, S Stricker, VG Magalhães, J Liebig, ... Nature biotechnology 40 (3), 319-324, 2022 | 327 | 2022 |
| Regulatory T cell specificity directs tolerance versus allergy against aeroantigens in humans P Bacher, F Heinrich, U Stervbo, M Nienen, M Vahldieck, C Iwert, K Vogt, ... Cell 167 (4), 1067-1078. e16, 2016 | 320 | 2016 |
| Alloantigen-induced CD25+ CD4+ regulatory T cells can develop in vivo from CD25− CD4+ precursors in a thymus-independent process M Karim, CI Kingsley, AR Bushell, BS Sawitzki, KJ Wood The Journal of Immunology 172 (2), 923-928, 2004 | 283 | 2004 |
| Interferon γ: a crucial role in the function of induced regulatory T cells in vivo KJ Wood, B Sawitzki Trends in immunology 27 (4), 183-187, 2006 | 279 | 2006 |
| Cutting edge: immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients JA Hutchinson, P Riquelme, B Sawitzki, S Tomiuk, P Miqueu, M Zuhayra, ... The Journal of Immunology 187 (5), 2072-2078, 2011 | 273 | 2011 |
| Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination L Loyal, J Braun, L Henze, B Kruse, M Dingeldey, U Reimer, F Kern, ... Science 374 (6564), eabh1823, 2021 | 269 | 2021 |
| Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1 SG Tullius, M Nieminen-Kelhä, R Buelow, A Reutzel-Selke, PN Martins, ... Transplantation 74 (5), 591-598, 2002 | 252 | 2002 |
| Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study M Streitz, T Miloud, M Kapinsky, MR Reed, R Magari, EK Geissler, ... Transplantation research 2, 1-15, 2013 | 245 | 2013 |
| Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells M Witkowski, C Tizian, M Ferreira-Gomes, D Niemeyer, TC Jones, ... Nature 600 (7888), 295-301, 2021 | 210 | 2021 |
| Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19 B Krämer, R Knoll, L Bonaguro, M ToVinh, J Raabe, ... Immunity 54 (11), 2650-2669. e14, 2021 | 204 | 2021 |
